More Life Genomics is a cooperative research project.
We are committed to exploring the therapeutic potential of Horizontal Gene Transfer as a medium to transform medicine.
This pioneering research effort is comprised of an interdisciplinary field of study conjoining chemical ecology, and evolutionary, molecular, and synthetic biologies.
We are specifically working to unravel the physical genetic synergies and decode the cognitive genetic symbiosis that exists between the plant and animal kingdoms.
Our quantitative research objectives have been primarily focused on gaining a comprehensive understanding of “how” and “why” these natural biological interactions occur across different species.
The next stage of pathbreaking research calls for isolating unique genetic materials (DNA) and facilitating the transfer of those selective genes between eukaryotes to prevent and treat specific diseases.
More Life Genomics is actively involved in deconstructing the deep biology of Allelopathy in the plant kingdom, and deliberately reconstructing this naturally occurring phenomenon in the animal kingdom.
Our preliminary analysis suggests Allelopathy via Horizontal Gene Transfer may have revolutionary ramifications as it relates to suspending or delaying the human aging process at a cellular level.
We are fostering a collaborative environment where thought leaders in academia have the opportunity to work together with trailblazing scientists and world-renowned clinicians to redefine medicine.
Our collective mission in 2024 is focused on discoveries and breakthroughs in eradicating premalignant clones that are the precursor to cancer cells.